论文信息 - Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary. - 字舞流文

Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary.

B. Griffith | C. Yancy | M. Acker | D. Mann | L. Stevenson | M. Slaughter | F. Pagani | J. Rogers | L. Miller | R. Starling | W. G. Stough | M. Jessup | K. Aaronson | R. Kormos | J. Teuteberg | D. Naftel | E. Blume | R. Higgins | S. Westaby | P. Wearden | T. Baldwin | S. Boyce | M. Mack

[1] Frederic S. Resnic,et al. Postmarketing surveillance of medical devices--filling in the gaps. , 2012, The New England journal of medicine.

[2] R. Hauser,et al. Here we go again--another failure of postmarketing device surveillance. , 2012, The New England journal of medicine.

[3] Aaron S Kesselheim,et al. Regulation of medical devices in the United States and European Union. , 2012, The New England journal of medicine.

[4] R. Redberg,et al. Medical devices--balancing regulation and innovation. , 2011, The New England journal of medicine.

[5] D. Challoner,et al. Medical devices and health--creating a new regulatory framework for moderate-risk devices. , 2011, The New England journal of medicine.

[6] Mitchell W Krucoff,et al. Clinical evaluation of cardiovascular devices: principles, problems, and proposals for European regulatory reform. Report of a policy conference of the European Society of Cardiology. , 2011, European heart journal.

[7] Harvey S Borovetz,et al. The national heart, lung, and blood institute pediatric circulatory support program: a summary of the 5-year experience. , 2011, Circulation.

[8] L. Stevenson,et al. Third INTERMACS Annual Report: the evolution of destination therapy in the United States. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[9] Lisa A Bero,et al. Strength of study evidence examined by the FDA in premarket approval of cardiovascular devices. , 2009, JAMA.

[10] S. Russell,et al. Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.

[11] Charles B Cairns,et al. Ethical and scientific implications of the globalization of clinical research. , 2009, The New England journal of medicine.

[12] Bram D. Zuckerman,et al. FDA perspective on clinical trial design for cardiovascular devices. , 2006, The Annals of thoracic surgery.

[13] A. Moskowitz,et al. Progress versus precision: challenges in clinical trial design for left ventricular assist devices. , 2006, The Annals of thoracic surgery.

[14] G. Felker,et al. Same bridge, new destinations rethinking paradigms for mechanical cardiac support in heart failure. , 2006, Journal of the American College of Cardiology.